Abstract:OBJECTIVE:To investigate the impact of primary hypertension on angiogenesis in the tissues of benign prostatic hyperplasia (BPH). METHODS:Immunohistochemistry was carried out to examine the expression of CD34, so as to calculate the microvassel density (MVD), and the expression of vascular endothelial growth factor (VEGF) in the tissues of prostatic gland, resected during operation, of 50 simple BPH patients, aged 68.3 (56 approximately 83), and 50 patients with BPH with hypertension, aged 69.0 (55 approximately 91) with a course of hypertension of 16.5 +/- 11.9 years (1 - 41 years). RESULTS:The MVD of the simple BPH group was 23.1 +/- 9.2, significantly lower than that of the BPH complicated with hypertension group (28.2 +/- 9.5, P < 0.01), especially the BPH complicated with hypertension group with a course >/= 15 years (31.3 +/- 8.5). The MVD of the BPH complicated with hypertension group with a course >/= 15 years was significantly higher than that of the BPH complicated with hypertension group with a course < 15 years (25.7 +/- 9.7, P < 0.05). The VEGF positive rate of the stroma of the simple BPH group was 46.0%, significantly lower than that of the BPH complicated with hypertension group (66.0%, P < 0.05), especially that of the BPH complicated with hypertension group with a course >/= 15 years (81.8%). The VEGF positive rate of the stroma of the BPH complicated with hypertension group with a course >/= 15 years was significantly higher than that of the BPH complicated with hypertension group with a course < 15 years (53.6%, P < 0.05). In the group of BPH with hypertension, MVD was positively correlated with the expression of VEGF in the stromal tissue (R = 0.11, P < 0.05). CONCLUSION:Hypertension may be closely related to the increased expression of VEGF in prostatic stroma. The increased expression of VEGF may induce angiogenesis and consequently lead to clinical progression of BPH in patients with hypertension.

Distribution and expression of angiotensin Ⅱ and angiotensin Ⅱ receptor AT1 in benign prostatic hyperplasia with and without concomitant hypertension

Effect of Hypertension on Bacteria Composition of Prostate Biopsy in Patients with Benign Prostatic Hyperplasia and Prostate Cancer in PSA Grey-Zone.

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

Effect of Hypertension on Cell Proliferation and Apoptosis in Benign Prostatic Hyperplasia

Associated study on expression of androgen receptor and type Ⅰ transforming growth factor- β receptor in BPH

Association Study Between Benign Prostatic Hyperplasia and Primary Hypertension

Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-β1 in prostate tissue of spontaneously hypertensive rats

[Impact of Hypertension on Angiogenesis in the Tissues of Benign Prostatic Hyperplasia].

Endothelin-1 and Its Receptors Expression in Prostatic Tissues of Patients with Benign Prostatic Hyperplasia

Regulation of CCN1 on angiogenesis in benign prostatic hyperplasia

Correlation study on the expression of transforming growth factor-β type I receptor and fibrohlast growth factor type I receptor in BPH

Plasma Angiotensin Ⅱ Type 2 Receptor in Relevant to Blood Pressure and Inflammatory Factors

Association Study Between Primary Hypertension and Benign Prostatic Hyperplasia

Expression of angiogenin in human prostatic adenocarcinoma and benign prostatic hyperplasia tissues

Relationship Between Angiotensin Ⅱ Type 1 Receptor/Autoantibodies in Plasma and Blood Pressure

[Expressions of Endothelin-1 in Benign Prostatic Hyperplasia and Prostate Cancer and Their Significance].

Expression of Angiotensin Ⅱ Receptor in Aldosterone-producing-adenoma

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

[Progress in the Studies of Alpha1-Receptor Blocker for Benign Prostatic Hyperplasia].

Study on the relationship of expression of AT1, AT2 in IgAN renal tissue with pathogenesis of proximal tubular cell transdifferentiation and renal interstitial vascular pathological changes

Changes of Th17 and Treg Cell Ratio in the Peripheral Blood of Patients with Benign Prostatic Hyperplasia